Hemophagocytic syndrome, a rare complication in patients with human immunodeficiency virus (HIV) infection. A case report
DOI:
https://doi.org/10.61182/rnavmed.v9n2a2Keywords:
Hemophagocytic syndrome, Hemophagocytic lymphohistiocytosis, Virus de inmunodeficiencia humanaAbstract
Hemophagocytic syndrome secondary to human immunodeficiency virus (HIV) constitutes a rare manifestation of this disease, characterized by nonspecific symptoms that often lead to delayed diagnosis, thereby limiting opportunities for early intervention.
Clinical case: We present the case of a 39-year-old man with a history of HIV diagnosed over ten years ago, who exhibited poor adherence to antiretroviral therapy (ART) and had restarted ART one month prior to his emergency admission due to a five-day history of symptoms. These symptoms included respiratory manifestations, fever, general malaise, and diarrhea. Physical examination revealed constitutional syndrome, stable vital signs, dehydration without the need for supplemental oxygen, no signs of abdominal peritoneal irritation, and large, bilateral, painless inguinal and cervical lymphadenopathies. A previous cervical lymph node biopsy had revealed a hematolymphoid neoplasm of large cells, consistent with non-Hodgkin lymphoma. Paraclinical studies showed severe leukopenia, normocytic anemia, chest X-ray with no evidence of pneumonic consolidation, and a positive RT-PCR for SARS-CoV-2. Due to elevated severity markers, an angiotomography was performed, which evidenced pulmonary thromboembolism (PTE). Tuberculosis studies were negative. Taken together, these findings suggested a high probability of hemophagocytic syndrome, based on the H-score.
References
(1) Deana A, Sanchez Tovar E, Sossi M, Segovia Gira C, Morici M, Merhar C, et al. Linfohistiocitosis hemofagocítica (HLH) en pacientes pediátricos. Experiencia de una institución. Revista Hematología. 2022 Dec 29;26(3):89–95.
(2) Salunke B, Savarkar S. Hemophagocytic Syndrome—An Approach to the Management. Indian Journal of Critical Care Medicine. 2019 Sep;23(S3):S191–6.
(3) Soy M, Atagündüz P, Atagündüz I, Sucak GT. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic. Rheumatol Int. 2021 Jan 25;41(1):7–18.
(4) Dos Santos G, Uría R, Silvera L, de los Santos C, Oliver C, Frantchez V, et al. Síndrome hemofagocítico: una rara complicación en el paciente con infección por el virus de inmunodeficiencia humana (VIH). Rev urug med interna. 2017;2(1):25–31.
(5) La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019 Jun 6;133(23):2465–77.
(6) Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. The Lancet. 2014 Apr;383(9927):1503–16.
(7) Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome. Arthritis & Rheumatology. 2014 Sep 26;66(9):2613–20.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Carlos Hernán Calderón-Franco, Tatiana A. López-Areiza, Estefanía Vargas-Reales, Diego A. Ortega-Gómez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.